Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (study code: JSKN027-101) of JSKN027, an independently developed ...
ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...
Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ...
LTR Pharma recently announced the dosing of the first patients in the Phase II study of SPONTAN ®, which is evaluating the safety, tolerability and pharmacokinetic profile of LTR Pharma’s rapid acting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results